Skip to Content

Cardinal Health Inc CAH Stock Quote

| Rating as of


Pre-Market: 89.05 0.04 | 0.04 %

| Currency in USD

  • Last Close 89.10
  • Sector Healthcare
  • Industry Medical Distribution
  • Investment Style Mid Blend
  • Day Range 88.99  –  89.92
  • Year Range 64.99  –  95.45
  • Market Cap 22.3357 Bil
  • Volume / Avg 129.0 /  2.2 Mil
  • Price / Sales 0.11
  • Price / Book
  • Forward Div Yield 2.13%
  • Trailing Div Yield 2.23%

Morningstar‘s Stock Analysis CAH

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Cardinal Health Ends Fiscal 2023 With Strong Results and Reaffirms Favorable Outlook for 2024

Keonhee Kim Equity Analyst

Business Strategy and Outlook

| Keonhee Kim |

Cardinal Health is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $190 billion in annual U.S. drug distribution sales in fiscal year 2023, the company supplies roughly a quarter of the overall market. Its two close competitors are Cencora and McKesson. Together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the U.S. market.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CAH

Company Profile CAH

Business Description

Cardinal Health is one of three leading pharmaceutical wholesalers in the U.S., engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

7000 Cardinal Place
Dublin, OH, 43017
Industry Medical Distribution
Employees 48,000

Related Articles CAH

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of CAH’s competitive advantage.

Cardinal Health Inc


Cencora Inc


McKesson Corp


HCA Healthcare Inc

−$0.27 (0.30%) +$2.15 (1.18%) −$1.62 (0.37%) −$0.77 (0.30%)
Market Cap
22.34 Bil37.14 Bil59.12 Bil68.93 Bil
Medical Distribution Medical Distribution Medical Distribution Medical Care Facilities

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Cardinal Health Inc Stock

Yes. CAH has a forward dividend yield of 2.25%. See CAH’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CAH’s market cap is 22.34 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CAH’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CAH’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CAH’s historical performance against its industry peers and the overall market.